Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, IDT Ink Co-Marketing Agreement for qPCR Products

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies and Integrated DNA Technologies today announced a co-marketing agreement for qPCR products.

The agreement covers Agilent's Mx3005P qPCR system and Brilliant qPCR reagents and IDT's PrimeTime qPCR assays.

Terms of the deal were not disclosed.

In a statement, Scott O'Brien, product line manager for Agilent's genomic division, said, "The partnership provides the benefit of performing 5' nuclease probe assays with qPCR reagents that have been extensively tested against competitor reagents and assays."

Coupling PrimeTime qPCR assays with the Brilliant master mix will enable researchers to expand the scope of their research, the two firms said in a joint statement, and added that the combination "will provide an excellent tool for validating discoveries resulting from next-generation sequencing and copy number variation studies."

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.